Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria

Clinical trial NCT07512596 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07512596
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia

Start date: 2026-07-01
Primary completion: 2027-07-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.